Pediatrics in Review
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Pediatrics in Review. 1988;10:68-95.)
© 1988 American Academy of Pediatrics

This Article
Right arrow Full Text (PDF)
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Chloramphenicol Use

Chloramphenicol inhibits protein synthesis (of bacterial and mammalian cells) by binding to ribosomes and is toxic to both bacteria and people. In tolerated doses, it is bactericidal for Haemophilus influenzae and Neisseria meningitidis and is bacteriostatic against Streptococcus pneumoniae, Salmonella, Shigella and streptococci. Most Pseudomonas are resistant. Its effectiveness against Gram-negative enteric rods is variable. It is active against virtually all anerobes.

For oral use, chloramphenicol is available in capsules of crystalline chloramphenicol and a suspension of the palmitate ester. For intravenous use, it is available as the sodium succinate ester. When given as an ester (either orally or intravenously), the first step in metabolism is the hydrolysis of the ester bond.







HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Pediatrics  Pediatrics in Review
Copyright © 1988 by the American Academy of Pediatrics.